Tokyo, Japan

Kazuhiro Masuzaki



 

Average Co-Inventor Count = 4.5

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Chiyoda-ku, JP (2012 - 2013)
  • Toyko, JP (2015)
  • Tokyo, JP (2010 - 2017)

Company Filing History:


Years Active: 2010-2017

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Kazuhiro Masuzaki: Innovator in Medicinal Chemistry

Introduction

Kazuhiro Masuzaki is a prominent inventor based in Tokyo, Japan, known for his significant contributions in the field of medicinal chemistry. With a total of seven patents to his name, Masuzaki focuses on developing novel compounds that can play a crucial role in medical treatments.

Latest Patents

One of Masuzaki's latest inventions involves the development of a benzene or thiophene derivative for use as a VAP-1 inhibitor. This innovative compound aims to provide a medicament for the prophylaxis or treatment of diseases associated with VAP-1. The detailed specifications present a compound represented by the formula (I), which is defined within the patent documentation, along with its pharmaceutically acceptable salts. This invention reflects Masuzaki's dedication to advancing medicinal chemistry and improving therapeutic options.

Career Highlights

Throughout his career, Kazuhiro Masuzaki has been associated with several notable companies, including R-Tech Ueno, Ltd. and Sucampo AG. His work in these organizations has allowed him to push the boundaries of innovation, particularly in the area of drug development, highlighting his expertise in the pharmaceutical industry.

Collaborations

Masuzaki has collaborated with various talented individuals in his field, most notably Tatsuya Matsukawa and Ryu Hirata. These partnerships have likely contributed to the success of his inventive projects and enriched his research endeavors, fostering a collaborative environment for innovation.

Conclusion

Kazuhiro Masuzaki exemplifies the spirit of innovation in medicinal chemistry. His recent patents and collaborations demonstrate his commitment to advancing healthcare solutions. As advancements in his research continue to emerge, he remains a key figure in the pursuit of effective treatments for diseases linked to VAP-1.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…